GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Omnicell, Inc. (OMCL) [hlAlert]

Rating:
Buy OMCL
up 160.12 %

Omnicell, Inc. (OMCL) rated Buy with price target $16 by Auriga U.S.A

Posted on: Wednesday,  Oct 6, 2010  8:25 AM ET by Auriga U.S.A

Auriga U.S.A rated Buy Omnicell, Inc. (NASDAQ: OMCL) on 10/06/2010, when the stock price was $13.14. Since
then, Omnicell, Inc. has gained 160.12% as of 01/07/2016's recent price of $34.18.
If you would have followed this Auriga U.S.A's recommendation on OMCL, you would have gained 160.12% of your investment in 1919 days.

Omnicell Inc., provides clinical infrastructure and workflow automation solutions that enable healthcare facilities to acquire, manage, dispense, and deliver medications and supplies more effectively and efficiently.

Auriga is committed to providing our clients with market information flow, investment ideas and access to industry experts. We strive to provide value through unique industry knowledge. Our growing research practice is being built with domain experts who have a strong reputation amongst institutional investors. Auriga’s research analysts have also been recognized by numerous industry publications including, The Wall Street Journal and Bloomberg. Our bottom-up fundamental approach is data point driven with a primary focus on growth sectors within the technology and healthcare verticals.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/6/2010 8:25 AM Buy
None
13.14 16.00
as of 12/31/2010
1 Week down  -7.52 %
1 Month up  3.58 %
3 Months up  6.11 %
1 YTD up  5.63 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/10/2010 8:25 AM Buy
None
12.65 15.00
10/20/2009 8:25 AM Hold
None
10.59 12.00
5/1/2009 8:25 AM Buy
None
10.10
2/18/2009 8:25 AM Hold
None
8.48 8.00
1/21/2009 8:25 AM Sell
None
7.36 7.00
1/13/2009 1:25 PM Buy
None
11.02 15.00
12/17/2008 8:25 AM Buy
None
12.31 16.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy